Navigation Links
Viertel Foundation Fellowship for leading cancer researcher
Date:11/8/2010

Walter and Eliza Hall Institute researcher Dr Ross Dickins has been awarded a Sylvia and Charles Viertel Charitable Foundation Fellowship worth $AUD975,000 over five years.

Dr Dickins, a laboratory head in the institute's Molecular Medicine division, is investigating the genes involved in cancer development, particularly leukaemia, using short hairpin RNA (shRNA) techniques he developed that help identify the function of genes by switching the genes on and off.

"The techniques harness a natural process of gene silencing known as RNA interference and allow us to quickly and effectively study multiple cancer genes in new ways," Dr Dickins said.

The Viertel Fellowship will allow Dr Dickins to continue his work towards identifying the normal function of genes recently implicated in leukaemia.

Dr Dickins said it was an honour to be named the 2010 Viertel Fellow.

"Charles Viertel was a hugely generous Australian philanthropist, yet during his lifetime he sought little public recognition," Dr Dickins said.

"It is a great privilege to receive a fellowship from the charitable foundation he established." Dr Dickins explained that the research supported by the fellowship aimed to better understand the genetic changes that bring about leukaemia. With that knowledge new therapeutic targets for cancer could be identified, he said.

"We are examining several genes that are known to be altered in human leukaemia, along with a new set of genes that are thought to be involved but whose functions in normal blood cells and leukaemia cells remain untested," Dr Dickins said.

"Ultimately, we hope that shRNA technology will accelerate cancer drug discovery by identifying genes that could be targeted by new therapeutic agents, in particular for leukaemias and lymphomas," he said.

"In an ideal future, the research will help match the genetic profile of a tumour with the best possible therapeutic agent to treat that particular tumour."

The Sylvia and Charles Viertel Charitable Foundation is one of the largest charitable foundations in Australia, awarding almost $9 million through its grant programs each year.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. Landenberger Foundation awards grant to Scripps Florida scientist to study HIV
2. Entomological Foundation names 2010 award winners
3. American Migraine Foundation launches new podcast series
4. UofL researcher receives grant from the National Science Foundation
5. Stem cell, artificial liver research receives Coulter Foundation funding at NJIT
6. The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011
7. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
8. 12 women scientists announced as winners of Elsevier Foundation TWOWS Awards
9. NYSCF receives $27 million grant from Robertson Foundation to promote stem cell research
10. International Osteoporosis Foundation honors longtime associate
11. More Than 100 Global and U.S. Municipal Leaders Join Mayor Daley, Business, Civic, Academic and Foundation Leaders at 2010 Richard J. Daley Global Cities Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viertel Foundation Fellowship for leading cancer researcher
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... 24, 2017 Biopharm Reports has carried ... use of nuclear magnetic resonance spectroscopy (NMR). This ... profiled current practices, developments, trends and end-user plans ... growth and opportunities. These areas include growth in ... needs and innovation requirements, hyphenated NMR techniques, main ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... and NEW YORK , ... Lumeon , a leading digital health company, ... a provider of telemedicine and remote patient monitoring, ... for telemedicine reimbursements.  DN Telehealth ... patients, in real-time, extending consultations beyond a physical ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of ...
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)...  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, parks ... head lice treatment salon to set up shop. But there,s ... a French bistro on E Madison Ave, and CEO ... old lice clinic, we pride ourselves on being a destination ... of the stigma associated with lice. Everyone can get lice ...
Breaking Biology Technology: